ACE and acute kidney injury: A recent meta-analysis of combination therapy to lower blood pressure in diabetic kidney disease demonstrated once again that angiotensin-converting enzyme (ACE) inhibitors and ARBs were the most effective agents at prolonging renal survival but that combination therapy needed to be balanced against the risks of hyperkalaemia and acute kidney injury [15].